Myeloma UK has supported patient access to treatments through our innovative Clinical Trial Network. Read details of how Myeloma UK has given patients early access to treatments on the clinical trial outcomes page.
Adaptive designs for early phase clinical trials in oncology with an application to myeloma
To help us understand how you use our website and tailor the site to meet your needs, we use analytics cookies. It’s important to remember we can’t identify individuals with this type of cookie, but it does give us an overview of what works well on our website and what doesn’t.